Abiomed to Present at Upcoming Investor Conferences

Rhea-AI Summary

Abiomed, Inc. (NASDAQ: ABMD) announced that CEO Michael R. Minogue will present at two upcoming virtual conferences. The first is the William Blair’s 41st Annual Growth Stock Conference on June 1st at 4:40pm CT, followed by the Jefferies Virtual Healthcare Conference on June 3rd at 2:00pm ET. The company designs medical devices to support circulatory health, allowing the heart to rest by enhancing blood flow. For more details, visit www.abiomed.com.

Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at William Blair’s 41^st Annual Growth Stock Conference (virtual) on Tuesday, June 1^st at 4:40pm CT and the Jefferies Virtual Healthcare Conference on Thursday, June 3^rd at 2:00pm ET.

ABOUT ABIOMED

Based in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. For additional information, please visit: www.abiomed.com.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements, including with respect to Abiomed's development of existing and new products, the Company's commercial growth, future business opportunities and pending regulatory approvals. The Company's actual results may differ materially from those anticipated in these forward-looking statements due to a number of factors, including uncertainties related to the scope, extent and duration of the impact of the COVID-19 pandemic, development, testing and related regulatory approvals, including the possibility of future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological changes, governmental requirements, litigation, future capital requirements and uncertainty of additional financing, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission (SEC), including its most recent Annual Report on Form 10-K and subsequent filings with the SEC. Readers of this press release are advised not to evaluate forward-looking statements, which reflect information available only as of the date of this release, as reliable information. The Company is under no obligation to release updates to these forward-looking statements to reflect events or circumstances occurring after the date of the release or as a result of the impact of unforeseen events.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210525005314/en/

FAQ

What will Michael R. Minogue discuss at the William Blair’s 41st Annual Growth Stock Conference?

Michael R. Minogue will present key insights about Abiomed's heart support technologies and business growth.

When is Abiomed's presentation at the Jefferies Virtual Healthcare Conference?

Abiomed's presentation at the Jefferies Virtual Healthcare Conference is scheduled for June 3rd at 2:00pm ET.

What is the focus of Abiomed's medical devices?

Abiomed's medical devices focus on providing circulatory support to allow the heart to rest and improve blood flow.

Where is Abiomed, Inc. headquartered?

Abiomed, Inc. is headquartered in Danvers, Massachusetts.

What is the stock symbol for Abiomed?

The stock symbol for Abiomed is ABMD.